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Received 24 August 2016; revised 28 September 2016; accepted 11 October 2016AbstractObjective: To evaluate the auditory function of an individual with genetically confirmed hemochromatosis.
Methods: A 57 year old male with mildly impaired sound detection thresholds underwent a range of behavioural, electroacoustic and elec-
trophysiologic assessments. These included the recording of otoacoustic emissions and auditory brainstem responses, measurement of monaural
temporal resolution and evaluation of binaural speech processing. Findings for this patient were subsequently compared with those of 80 healthy
controls with similar audiometric thresholds.
Results: The patient showed the three cardinal features of auditory neuropathy, presenting with evidence of normal cochlear outer hair cell
function, disrupted neural activity in the auditory nerve/brainstem and impaired temporal processing. His functional hearing ability (speech
perception) was significantly affected and suggested a reduced capacity to use localization cues to segregate signals in the presence of back-
ground noise.
Conclusion: We present the first case of an individual with hemochromatosis and auditory neuropathy. The findings for this patient highlight the
need for careful evaluation of auditory function in individuals with the disorder.
Copyright © 2016, PLA General Hospital Department of Otolaryngology Head and Neck Surgery. Production and hosting by Elsevier
(Singapore) Pte Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Hemochromatosis is a hereditary disorder characterized by
excessive absorption and storage of iron from the diet. Excess
iron is deposited in various organs including the skin (causing
bronze pigmentation), the heart (causing arrhythmia), the
testes (causing loss of libido) and the pancreas (causing dia-
betes) (Neumann, 1948). Primary hemochromatosis is typi-
cally caused by a mutation of the HFE gene located on* Corresponding author. Department of Audiology and Speech Pathology,
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several environmental factors (including dietary iron intake
and alcohol consumption) and is 5e10 times more common in
men than women. Symptoms appear between the ages of 40
and 60 years in approximately 70% of individuals (Neumann,
1948).
The effects of excessive iron on the auditory system are yet
to be fully explored, but there is some evidence that both
chronic and acute iron deposition can impair function. Su-
perficial siderosis is a disorder of the central nervous system in
which repeated haemorrhaging into the subarachnoid space
leads to accumulation of hemosiderin (iron oxide) deposits in
neuronal tissues close to the cerebrospinal fluid (Gao et al.,
2015). The most susceptible cells are those in the cere-
bellum and auditory pathway and both intracochlear damage
and VIIIth nerve demyelination/axonopathy have beena patient with hemochromatosis, Journal of Otology (2016), http://dx.doi.org/
gy Head and Neck Surgery. Production and hosting by Elsevier (Singapore)
eativecommons.org/licenses/by-nc-nd/4.0/).
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Sydlowski et al., 2009). As a result, progressive hearing
impairment is a cardinal feature of the disease (Koeppen and
Dentinger, 1988; Fearnley et al., 1995; Kobayashi et al.,
2004). Furthermore, sudden hearing loss has recently been
associated with mutations in genotypes such as FPN1e8 GG
which is thought to control iron homeostasis in the inner ear
(Castiglione et al., 2015).
The primary neurologic signs of hemochromatosis are
progressive ataxia, gait disturbance and hearing loss
(Neumann, 1948). Progressive hearing deficit (as measured by
impaired sound detection thresholds) has been reported in
patients with the disease (Lewey and Govons 1942; Neumann,
1948) but the underlying mechanisms and functional conse-
quences have not been fully considered. In this study we
compare peripheral auditory function, auditory processing and
binaural speech perception findings for an individual with
hemochromatosis with those obtained from a of group healthy
matched controls.2. Materials and methods
This study was approved by the Human Research Ethics
Committee of the Royal Victorian Eye and Ear Hospital,
Melbourne, Australia and conformed to the tenets of the
Declaration of Helsinki. Informed consent was obtained
following explanation of the project's nature, purpose and
expected outcomes.2.1. ParticipantsPatient DM was recruited through the Medical Retina
Clinic at the Royal Victorian Eye and Ear Hospital as part of a
broader study investigating auditory function in individuals
with Type 1 diabetes (T1DM). He was aged 57 years at
assessment and had been diagnosed with hemochromatosis at
aged 47 years following genetic testing which indicated a
C282Y mutation of the HFE gene. His clinical presentation
included liver failure, hypertension, hypogonadism, Charcot's
(neuropathic) anthropathy and diabetes due to pancreatic dis-
ease. The patient's diabetes was managed via a daily subcu-
taneous insulin regimen and at the time of assessment his
glycated haemoglobin levels (HBA1c) were mildly elevated
(8.8%). Neurological history and physical examination
showed evidence of distal symmetrical polyneuropathy with
abnormal responses across a range of sensory modalities
(Michigan Neuropathy Screening Instrument [MNSI] rating:
2). His visual acuity was significantly impaired (LogMAR:
0.8) with evidence of proliferative diabetic retinopathy (Airlie
House Classification System: 4) and macular oedema (Airlie
House Classification System: 2). Audiometric thresholds were
mildly elevated, with both ears showing 4-frequency average
hearing levels of 26.25 dBHL (Fig. 1A). Despite these
impaired sound detection levels, robust Distortion Product
Otoacoustic Emission (DPOAE) responses were observed
bilaterally (Fig. 1B and C).Please cite this article in press as: Rance, G., Chisari, D., Auditory neuropathy in
10.1016/j.joto.2016.10.002Auditory findings for Patient DM were compared with data
from 80 healthy control subjects with sound detection
thresholds in the mild hearing loss range (4 frequency average:
24.7 ± 5.2 dBHL). Selected results for these individuals (39
female) have been published previously (Rance et al., 2012a,
2012b; 2014). Age at assessment for the group ranged from
10 years to 76 years (52.2 ± 14.9 years).2.2. Experimental proceduresEach subject underwent audiometric assessment using ER-
4 insert phones and a portable audiometer in a quiet room
where background noise levels were less than 40 dBA. Sound
detection thresholds were established at octave frequencies
across the audiometric range (250 Hze8 kHz) using standard
threshold seeking techniques. A 4-frequency average level
based on hearing thresholds at 500-, 1000-, 2000- and 4000 Hz
was calculated for each ear.
Auditory brainstem responses (ABRs) were recorded to
100 ms acoustic click stimuli presented to each ear individually
at 90 dBnHL. Electroencephalographic samples following
2000 clicks were averaged to produce each test run. Responses
were obtained to clicks at presentation rates of 8 Hz, 33 Hz,
57 Hz, 75 Hz and 100 Hz. A minimum of two runs were
obtained in each stimulus condition and compared to deter-
mine waveform repeatability. The highest rate at which a
repeatable ABR could be observed was determined for each
ear. Furthermore, post-stimulus latency of ABR waves I, III
and V and the wave V/I peak-to-peak amplitude ratio was
established for the 8 Hz presentation rate.
Temporal resolution (the ability to perceive changes in
auditory signals over time) was assessed using an amplitude
modulation (AM) detection task. The psychophysical protocol
employed an adaptive, three-alternative, forced-choice pro-
cedure to determine the 70.7% correct response criterion. The
experiment sought the threshold for detection of sinusoidal
AM occurring at two rates: 10 Hz and 150 Hz. The back-
ground stimuli were broadband noisebursts and the modulated
(target) stimuli were derived by multiplying the noiseburst by
a dc-shifted sine wave as per Rance et al. (2004). Depth of
modulation was determined by the amplitude of the modu-
lating sine wave and stimuli with AM depths, defined as
20 logm, varied from 0 to 30 dB (in 3 dB increments).
Binaural speech perception assessment was carried out
using the Listening in Spatialized Noise (LISN-S) test which
measures the subject's ability to segregate a target speech
signal from a competing speech noise (Cameron and Dillon,
2007). The test is administered under headphones, but a 3-
dimensional auditory environment is created by synthesizing
the test stimuli using a head-related transfer function
(Cameron and Dillon, 2008). Speech reception threshold (the
signal-to-noise ratio required for the listener to identify 50%
of the words in target sentences) is established in 4 conditions
which vary in terms of the location of the noise source (0
versus 90 azimuth) and vocal quality of the speaker (same or
different talker used to produce the target and background
signals).a patient with hemochromatosis, Journal of Otology (2016), http://dx.doi.org/
Fig. 1. Behavioural audiogram (Panel A) and Distortion Product Otoacoustic Emission (Panel B and Panel C) results for Patient DM.
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+ MODEL3. Results3.1. Auditory brainstem responseSubject DM showed repeatable ABR waveforms to
acoustic click stimuli presented to each ear at the 8 Hz pre-
sentation rate. Waveform latencies are shown in Table 1.
Absolute peak latencies for wave I and wave V for each ear
were within the control group normative range (mean ± 2SD),
but wave III latencies were prolonged. Interpeak latencies
(IIIeV) were normal, but wave IeIII interpeak times
were significantly longer (>mean þ 2 SD) than those of the
control participants. Response amplitudes (wave V/I ratio) for
patient DM were within the control group mean ± 2 SD range
(Table 1).
Auditory brainstem potentials for Subject DM were
abnormally affected by increases in stimulus presentation rate.
Mean maximum rate with a recordable ABR for the control
group was 97.9 ± 7.0 Hz. Patient DM, in contrast, only
showed an ABR to acoustic clicks presented to the left ear at
8 Hz (Fig. 2A). For the right ear, repeatable responses were
observed for presentation rates 75 Hz (Fig. 2B), but wave-
forms to high rate stimuli were significantly delayed relative to
controls (Fig. 2C).3.2. Auditory temporal processingIdentification of rapid sinusoidal amplitude modulation was
impaired in Subject DM. While his AM detection thresholds to
low rate stimuli (10 Hz) fell within the control group norma-
tive range (mean ± 2 SD), his high rate AM thresholds
(150 Hz) for stimuli presented to both the left and right ears
were significantly higher (worse) than those of the controlTable 1
ABR findings to 90 dBnHL acoustic click stimuli presented at a rate of 8 Hz.
Waveform latencies (8 Hz)
I III V IeIII
Control group mean (SD) 1.48 (0.14) 3.66 (0.10) 5.54 (0.24) 2.18 (0.
DM (left Ear) 1.32 3.86 5.50 2.54
DM (right Ear) 1.32 3.90 5.48 2.58
Please cite this article in press as: Rance, G., Chisari, D., Auditory neuropathy in
10.1016/j.joto.2016.10.002cohort (Fig. 3). This pattern is indicative of temporal pro-
cessing disorder. Normal identification of modulation at 10 Hz
suggests unimpaired discrimination of signal level variations.
Depressed AM detection at 150 Hz, in contrast, reflects an
impaired capacity of the auditory pathway to encode signal
changes occurring over a brief time course (Rance et al.,
2010).3.3. Binaural speech perception in noiseSubject DM showed impaired speech perception in back-
ground noise for listening conditions in which binaural dif-
ference cues were available. For both the DV90 (different
voices/target and background speech spatially separated by
90) and SV90 (same voice/target and background separated
by 90) conditions, his speech reception threshold was poorer
than the mean ± 2 SD performance range of the control cohort
(Fig. 4). In contrast, his performance for listening conditions
in which the target speech and noise were co-located (DV0
and SV0) was within the normal range (Fig. 4).
4. Discussion
The hemochromatosis patient described in this study pre-
sented with the 3 cardinal features of the auditory neuropathy
(AN) type hearing loss: normal cochlear outer hair cell func-
tion (with robust otoacoustic emission responses bilaterally),
disrupted neural conduction in the auditory nerve/brainstem
and impaired processing of auditory temporal cues.
Repeatable auditory brainstem responses were obtained (to
low rate stimuli) in each ear, but absolute peak latencies (wave
III) were increased in each ear relative to matched controls.
Wave IeIII inter-peak latencies were also prolongedAmplitude ratio (V/I) Maximum rate
IIIeV IeV
14) 1.88 (0.14) 4.05 (0.18) 2.21 (1.44) 97.92 (7.01)
1.64 4.18 0.90 8.0
1.58 4.16 1.68 75.0
a patient with hemochromatosis, Journal of Otology (2016), http://dx.doi.org/
Fig. 2. Auditory brainstem responses for Subject DM to acoustic click stimuli at presentation rates ranging from 8 Hz to 100 Hz. Findings for stimuli presented to
the left ear are shown in Panel A and to the right ear are shown in Panel B. Tracings for a typical control subject are shown in Figure C.
Fig. 3. Amplitude modulation detection thresholds for Subject DM (unfilled data points) and hearing-level matched controls (filled data points). The shaded area
represents the mean ± 2 SD range for the control group. Panel A shows findings for stimuli modulated at a rate of 10 Hz. Panel B shows findings for amplitude
modulation at a rate of 150 Hz.
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+ MODELbilaterally indicating reduced conduction velocity between the
distal portion of the auditory nerve and the cochlear nucleus.
The mechanism(s) underlying this result pattern is unclear, but
post-mortem histologic investigation in another hemochro-
matic patient with similar neurologic history (progressive
bilateral hearing loss and balance disturbance), revealed evi-
dence of pyknotic degenerative changes in the VIIIth nerve
dorsal nucleus (Neumann, 1948).
Abnormal brainstem responses to high rate stimuli were
also observed in Patient DM. The effect of stimulus rate on thePlease cite this article in press as: Rance, G., Chisari, D., Auditory neuropathy in
10.1016/j.joto.2016.10.002ABR in normally-hearing adults is well understood with
numerous studies showing consistent latency prolongation and
amplitude reduction as presentation rate is increased beyond
20 Hz (Don et al., 1977; Picton et al., 1981; Burkhard et al.,
1990). Rate effects in individuals with neuropathology have
been less well explored, but abnormal latency shifts and
disappearance of later ABR waves have been described for a
range of peripheral and CNS pathologies including acoustic
neuroma (Daly et al., 1977), hypoxia (Hecox et al., 1981),
mixed CNS disease (Pratt et al., 1981; Fowler and Noffsinger,a patient with hemochromatosis, Journal of Otology (2016), http://dx.doi.org/
Fig. 4. Binaural speech perception in noise results for Subject DM (unfilled data points) and for a cohort of hearing-level matched controls. Panels A and B show
listening conditions in which the target speech and noise are spatially separated (A: different voices with noise and signal separated by 90; B: same voice with
noise and signal separated by 90). Panels C and D show conditions in which the speech and noise emanate from the same direction (C: different voices with noise
and signal separated by 0; D: same voice with noise and signal separated by 0). The shaded area in each case represents the mean ± 2 SD range for the control
cohort.
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1981; Fowler and Noffsinger, 1983). In the present case, the
maximum stimulus rate at which an ABR could be discerned
for the left ear was significantly reduced (8 Hz) suggesting that
his auditory neural system was more easily stressed beyond its
functional capacity than those of the healthy controls. For the
right ear, responses could be seen at higher rates (up to 75 Hz),
but latency delays were greater than typical, again suggesting
the presence of auditory neural dysfunction. The mechanisms
underlying this rate vulnerability in our patient are uncertain,
but similar patterns have been reported from experimental
studies of induced axonal, demyelinating and neuronal syn-
apse disorders (McDonald and Sears, 1970; Saha et al., 1978).
Consistent with this electrophysiologic sensitivity to high
rate acoustic signals, Patient DM also showed impaired
perception of auditory timing cues. Amplitude modulation
detection to high rate stimuli (150 Hz) was poorer than that of
healthy controls, indicating an impaired ability to encode
signal changes occurring over a brief (6e7 ms) time course.
Temporal resolution deficit is common in auditory neuropathy
and has been described in patient populations withPlease cite this article in press as: Rance, G., Chisari, D., Auditory neuropathy in
10.1016/j.joto.2016.10.002demyelinating disease such as CharcoteMarieeTooth disease
(Type 1) (Starr et al., 2003; Rance et al., 2012c) and peripheral
nerve axonopathy such as CharcoteMarieeTooth disease
(Type 2) and Friedreich ataxia (Rance et al., 2010, 2012a). In
the case of demyelinating neuropathy, the temporal disruption
is thought to occur when loss of the neural insulator results in
slowed and/or inconsistent conduction of neural signals and a
reduced capacity to transmit trains of pulses (Brown and
Watson, 2002). Axonopathy may produce temporally incon-
sistent neural conduction through secondary demyelination
and/or conduction block (Brown and Watson, 2002).
The major functional consequence of auditory neuropathy
is an impaired ability to hear and understand speech. This
deficit occurs primarily because perception of subtle timing
differences between phonemes (speech sounds) is crucial to
their identification (Rance et al., 2010). As such, the degree of
temporal distortion, rather than audibility, is typically the
limiting factor in speech understanding (Rance et al., 2004,
2012a, 2012b, 2012c; Zeng et al., 2005). In addition to
signal distortion issues, temporal processing deficit also cre-
ates particular problems for listening in background noisea patient with hemochromatosis, Journal of Otology (2016), http://dx.doi.org/
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to occur in part because of a reduced ability to use brief quiet
periods in the background noise to access the speech signal
(gap listening) (Alcantara et al., 2004) and in part because of
an impaired ability to spatially separate sound sources based
on interaural timing cues (spatial streaming) (Rance et al.,
2012a). The second of these mechanisms was reflected in
the findings for Patient DM who showed normal perception
when speech and noise were presented from the same direction
(i.e. there were no interaural difference cues) but significantly
reduced release from masking for conditions in which the
signal and noise were emanating from different directions.
Where control subjects obtained (on average) a 12 dB
improvement in Speech Reception Threshold when speech and
noise were separated by 90, Patient DM was afforded only a
6 dB improvement. This degree of deficit is functionally sig-
nificant, and in everyday (noisy) listening conditions is likely
to impact communication ability, increase stress and impair
cognitive function (Hetu et al., 1990).
5. Study limitations
Excessive iron in the auditory system is a plausible aeti-
ology for Patient DMs auditory deficits as pathologic changes
to the cochlear nucleus have been demonstrated previously in
Hemochromatosis. However, it is possible in this case, that the
AN was the result of diabetic peripheral neuropathy. Auditory
neuropathy and temporal processing deficit have also been
described in patients with Type 1 diabetes (Rance et al., 2014)
where the auditory deficit may occur as part of a generalized
neuropathic process affecting both the motor and sensory pe-
ripheral nervous systems (Callaghan et al., 2012a, 2012b; Rao
and Dlouhy, 2012). The exact pathophysiology of peripheral
neuropathy in diabetes is yet to be defined, but one or more of
polyol accumulation, injury from advanced glycosylated end
products (AGEs), and oxidative stress are thought to be
involved (Fowler, 2008). As Patient DM had suffered diabetes
secondary to the hemochromatosis for 15 years at the time of
assessment, and had presented with a neurologic history
consistent with Diabetic Peripheral Neuropathy, it is possible
that his auditory deficits were, in fact, the result of diabetic
sequelae rather than excessive iron deposition. One point of
difference between the “typical” diabetic neuropathy pattern
and that demonstrated by patient DM is that he only showed
ABR changes up to the level of the cochlear nucleus. Diabetic
AN usually affects neural conduction in this region and also up
to the level of the lateral lemniscus (Parving et al., 1990;
Lisowska et al., 2001; Pessin et al., 2008; Rance et al.,
2014). This difference may prove to be diagnostically signif-
icant, but further data is required.
While the ABR findings for Patient DM indicate abnor-
mality in the VIIIth nerve and brainstem, is it possible that
iron-related changes to his brain were not restricted to this
region and that his hearing difficulties may (in part) have been
caused by lesions at other sites. Hemochromatic changes and
concomitant neurological sequelae have, for example, beenPlease cite this article in press as: Rance, G., Chisari, D., Auditory neuropathy in
10.1016/j.joto.2016.10.002shown in the central nervous system of affected patients
(Lewey and Govons 1942; Neumann, 1948). The degree of
CNC involvement in Patient DM was uncertain, but it is well
established that other CNS disorders, such as multiple scle-
rosis can result in auditory (temporal) processing disorder and
impaired functional hearing (Furst and Levine, 2015).
6. Summary
Hearing problems have been reported previously in in-
dividuals with hemochromatosis, but this study is the first to
identify the auditory neuropathy result pattern in an individual
with the disorder. The findings of this case study highlight the
need for careful audiologic evaluation of patients diagnosed
with Hemochromatosis. This is particularly important for in-
dividuals (such as Patient DM) who also present with visual
deficits as it is well established that combined visual/auditory
impairment can have significant cumulative effects on func-
tional status, independence and well-being in patients if un-
recognized (Chia et al., 2006).
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